ImmunoPET: concept, design, and applications

W Wei, ZT Rosenkrans, J Liu, G Huang, QY Luo… - Chemical …, 2020 - ACS Publications
Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

Click chemistry: a transformative technology in nuclear medicine

D Bauer, SM Sarrett, JS Lewis, BM Zeglis - Nature protocols, 2023 - nature.com
Abstract The 2022 Nobel Prize in Chemistry was awarded to Professors K. Barry Sharpless,
Morten Meldal and Carolyn Bertozzi for their pioneering roles in the advent of click …

[HTML][HTML] Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities

PI Siafaka, NÜ Okur, ID Karantas, ME Okur… - Asian Journal of …, 2021 - Elsevier
In the last decade, the use of nanotheranostics as emerging diagnostic and therapeutic tools
for various diseases, especially cancer, is held great attention. Up to date, several …

Click chemistry and radiochemistry: an update

D Bauer, MA Cornejo, TT Hoang, JS Lewis… - Bioconjugate …, 2023 - ACS Publications
The term “click chemistry” describes a class of organic transformations that were developed
to make chemical synthesis simpler and easier, in essence allowing chemists to combine …

Zirconium immune-complexes for PET molecular imaging: current status and prospects

L Melendez-Alafort, G Ferro-Flores, L De Nardo… - Coordination Chemistry …, 2023 - Elsevier
Diagnostic molecular images, obtained by positron emission tomography (PET), have
successfully functioned as sensitive tools for detecting and monitoring the treatment of …

Not so innocent: Impact of fluorophore chemistry on the in vivo properties of bioconjugates

SM Usama, ER Thapaliya, MP Luciano… - Current opinion in …, 2021 - Elsevier
The combination of targeting ligands and fluorescent dyes is a powerful strategy to observe
cell types and tissues of interest. Conjugates of peptides, proteins, and, in particular …

Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab …

GA Ulaner, JA Carrasquillo, CC Riedl, R Yeh… - Radiology, 2020 - pubs.rsna.org
Background Human epidermal growth factor receptor 2 (HER2)-targeted therapies are
successful in patients with HER2-positive malignancies; however, spatial and temporal …

Development of antibody immuno-PET/SPECT radiopharmaceuticals for imaging of oncological disorders—an update

J Dewulf, K Adhikari, C Vangestel, TVD Wyngaert… - Cancers, 2020 - mdpi.com
Positron emission tomography (PET) and single-photon emission computed tomography
(SPECT) are molecular imaging strategies that typically use radioactively labeled ligands to …

Lysine-directed site-selective bioconjugation for the creation of radioimmunoconjugates

SM Sarrett, C Rodriguez, G Rymarczyk… - Bioconjugate …, 2022 - ACS Publications
The synthesis of radioimmunoconjugates via the stochastic attachment of bifunctional
chelators to lysines can yield heterogeneous products with suboptimal in vitro and in vivo …

First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer

R Yeh, JA O'Donoghue… - Journal of Nuclear …, 2024 - Soc Nuclear Med
Radioimmunoconjugates targeting human epidermal growth factor receptor 2 (HER2) have
shown potential to noninvasively visualize HER2-positive tumors. However, the stochastic …